These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1824984)

  • 1. RATG treatment induces suppressor cells in primates.
    Emara M; Carver FM; Thomas JM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):302-4. PubMed ID: 1824984
    [No Abstract]   [Full Text] [Related]  

  • 2. Veto cells induce long-term kidney allograft tolerance in primates without chronic immunosuppression.
    Thomas JM; Carver FM; Cunningham P; Olsen L; Thomas FT
    Transplant Proc; 1991 Feb; 23(1 Pt 1):11-3. PubMed ID: 1824966
    [No Abstract]   [Full Text] [Related]  

  • 3. Establishment of a human T-cell hybridoma producing an MLR suppressing factor: relationship to the mechanism of action of donor-specific transfusion.
    Haisa M; Sakagami K; Orita K
    Transplant Proc; 1990 Aug; 22(4):1977-80. PubMed ID: 2143868
    [No Abstract]   [Full Text] [Related]  

  • 4. Posttransplant TLI is effective in nonhuman primates if combined with rabbit ATG.
    Carver M; Alqaisi M; Cunningham P; Gross U; Thomas F; Thomas J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):480-2. PubMed ID: 1899310
    [No Abstract]   [Full Text] [Related]  

  • 5. Function and specificity of suppressor T-cells and factors derived from a human renal allograft recipient.
    Emara M; Finn O; Baldwin WM; Sanfilippo F
    Transplant Proc; 1989 Feb; 21(1 Pt 1):361-4. PubMed ID: 2523134
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppressor activity of blood lymphocytes from guinea-pigs treated with ALS.
    Rudnicka W
    Immunology; 1980 Mar; 39(3):435-40. PubMed ID: 6449472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of T-Suppressors concentrated by elution from an allogeneic cell monolayer].
    Abronina IF; Karaulov AV; Brondz BD
    Biull Eksp Biol Med; 1980 Feb; 89(2):202-5. PubMed ID: 6445215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of DNA synthesis in lymphocytes from ALG-treated patients.
    Möller G; Lundgren G
    Clin Exp Immunol; 1970 Feb; 6(2):299-304. PubMed ID: 4907964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prostaglandin-dependent immunoregulatory mechanism activated by in vivo administration of antithymocyte globulin.
    Thomas JM; Carver FM; Fahrenbruch GB; Hall WR; Deepe RM; Thomas FT
    Surgery; 1983 Aug; 94(2):384-91. PubMed ID: 6224306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stem cell inactivation by allogenic lymphocytes: characteristics of suppressor cells blocking the killer action of syngeneic lymphocytes].
    Ignat'eva GA; Man'ko VM; Dishkant IP
    Tsitologiia; 1981 Dec; 23(12):1386-94. PubMed ID: 6460363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage as a suppressor cell or a helper cell in human renal transplant patients.
    Kaneda I; Miura K; Sasaki T; Jimbo M; Satomi S; Okazaki H; Taguchi Y; Kasai M
    Transplant Proc; 1981 Mar; 13(1 Pt 1):678-81. PubMed ID: 6455810
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of suppressor T cells in vitro by an autologous alloreactive T cell line propagated from a DSBT-enhanced rat renal allograft.
    Ruiz P; Baldwin WM; Sanfilippo F
    Transplant Proc; 1989 Apr; 21(2):3289-91. PubMed ID: 2565616
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow cells that prolong graft survival in ALS-treated mice: suppressor activity in mixed cell culture.
    De Fazio SR; Monaco AP; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):228-30. PubMed ID: 2523127
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific tolerance to canine renal allografts following treatment with fractionated bone marrow and antilymphocyte serum.
    Hartner WC; De Fazio SR; Markees TG; Maki T; Monaco AP; Gozzo JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):476-7. PubMed ID: 3274810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of anti-lymphocyte globulins made from thoracic duct lymphocytes.
    Traeger J; Carraz M; Fries D; Perrin J; Saubier E; Bernhardt JP; Revillard JP; Bonnet P; Archimbaud JP; Brochier J
    Transplant Proc; 1969 Mar; 1(1):455-9. PubMed ID: 4332532
    [No Abstract]   [Full Text] [Related]  

  • 16. Donor bone marrow infusion suppresses alloantibody response in RATG-treated recipients: a correlate of long survival.
    Thomas JM; Carver FM; Cunningham PR; Gross U; Verbanac KM; Rebellato LM; Riley R; Thomas FT
    Transplant Proc; 1993 Feb; 25(1 Pt 1):342-3. PubMed ID: 8438326
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys.
    Thomas JM; Carver FM; Foil MB; Hall WR; Adams C; Fahrenbruch GB; Thomas FT
    Transplantation; 1983 Jul; 36(1):104-6. PubMed ID: 6346606
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of second-set rejection by cyclosporine-resistant suppressor cells in a rat renal allograft model.
    Freitas Rodrigues MA; Hutchinson IV; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):365-6. PubMed ID: 2523135
    [No Abstract]   [Full Text] [Related]  

  • 19. Generation of suppressor cells by administration of deaggregated horse anti-human thymocyte globulin in man.
    Abdou NI
    Transplant Proc; 1981 Mar; 13(1 Pt 1):512-4. PubMed ID: 6455799
    [No Abstract]   [Full Text] [Related]  

  • 20. Enterically induced regulation of systemic immune responses. II. Suppression of proliferating T cells by an Lyt-1+, 2- T effector cell.
    Silverman GA; Peri BA; Fitch FW; Rothberg RM
    J Immunol; 1983 Dec; 131(6):2656-61. PubMed ID: 6196395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.